Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging fungal diseases.

Marcio Nucci1, Kieren A Marr

  • 1University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|July 20, 2005
PubMed
Summary

Invasive fungal infections are changing, with non-Candida yeasts and non-Aspergillus molds becoming more common in immunocompromised patients due to host factors and medical interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing Breakthrough Fungal Infections in Hematologic Patients: Determinants and Practical Management from a Latin American Perspective on Behalf of INFOCUS LATAM-ISHAM Working Group.

Microorganisms·2026
Same author

Repeat Blood Cultures in Persistent Febrile Neutropenia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study.

BMC infectious diseases·2026
Same author

Management of fusariosis in transplant patients.

Expert review of anti-infective therapy·2026
Same author

Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies.

The Journal of antimicrobial chemotherapy·2026
Same author

Clinical Features and Mortality of Chronic Pulmonary Aspergillosis in Brazil: a Multicenter Cohort Study.

Open forum infectious diseases·2026

Area of Science:

  • Medical Mycology
  • Infectious Diseases Epidemiology
  • Immunocompromised Host Infections

Background:

  • The landscape of invasive fungal infections (IFIs) is shifting.
  • Non-albicans Candida yeasts and non-fumigatus Aspergillus molds are increasingly implicated in IFIs.
  • Severely immunocompromised patients are at heightened risk.

Purpose of the Study:

  • To review the evolving epidemiology of emerging fungal infections.
  • To identify factors contributing to the rise of these infections.
  • To discuss the clinical and practical implications of these epidemiological changes.

Main Methods:

  • Literature review of recent epidemiological data on IFIs.
  • Analysis of factors influencing the emergence of fungal pathogens.
  • Discussion of impact on specific patient populations.

Main Results:

  • Emergence of yeasts beyond Candida albicans and molds beyond Aspergillus fumigatus as significant pathogens.
  • Changes in host factors, including increased severity and types of immunosuppression, are key drivers.
  • Epidemiological shifts observed in organ transplant recipients, neonates, and critically ill patients.

Conclusions:

  • The epidemiology of IFIs is dynamic, driven by host and iatrogenic factors.
  • Understanding these shifts is crucial for managing infections in vulnerable populations.
  • Proactive strategies are needed to address the changing spectrum of IFIs.

Related Experiment Videos